Director of Business Development, Life Sciences

About Rhino

Rhino Federated Computing Rhino solves one of the biggest challenges in AI: seamlessly connecting siloed data through federated computing. The Rhino Federated Computing Platform (Rhino FCP) serves as the ‘data collaboration tech stack’, extending from providing computing resources to data preparation & discoverability, to model development & monitoring - all in a secure, privacy preserving environment. To do this, Rhino FCP offers flexible architecture (multi-cloud and on-prem hardware), end-to-end data management workflows (multimodal data, schema definition, harmonization, and visualization), privacy enhancing technologies (e.g., differential privacy), and allows for the secure deployment of custom code & 3rd party applications via persistent data pipelines. Rhino is trusted by >60 leading organizations worldwide - including 14 of 20 of Newsweek’s ‘Best Smart Hospitals’ and top 20 global biopharma companies - and is leveraging this foundation for financial services, ecommerce, and beyond.

The company is headquartered in Boston, with an R&D center in Tel Aviv.

About the Role

We’re seeking a Director of Business Development to drive growth across our rapidly expanding Life Sciences business. Reporting directly to the VP, Life Sciences, you’ll be responsible for cultivating strategic relationships with biopharma and biotech partners, advancing enterprise opportunities, and helping bring cutting-edge federated data and AI solutions to therapeutic R&D, clinical development, and real-world evidence generation.

You’ll join a fast-moving, mission-driven team redefining how systems learn: via secure, privacy-preserving collaborations that enable global data access and analytics.

Key Responsibilities

• Drive new business and revenue growth across the biopharma ,biotech, and techbio sectors by identifying, qualifying, and closing enterprise software and data collaboration opportunities.


• Own the full sales cycle, from prospecting and solution scoping to proposal, negotiation, and close, and in collaboration with customer solutions and product teams.


• Partner with the VP, Life Sciences to execute on the go-to-market strategy, pipeline prioritization, and customer engagement models.


• Translate complex technology (AI/ML, federated computing, data harmonization, privacy-enhancing technologies) into clear, outcome-driven value propositions for R&D, clinical development, RWE and digital innovation teams.


• Build and maintain key relationships with stakeholders in biopharma, biotech, techbio, CROs, and research consortia.


• Collaborate cross-functionally with Product, Solutions and Marketing to ensure consistent messaging and successful prospect engagements.


• Track and report pipeline metrics, forecasts, and progress toward quarterly and annual targets.

Our target outcomes for this role are (1) new logos and (2) annual recurring revenue.

Qualifications

• 5+ years of experience selling technical or software solutions (AI platforms, data analytics, or enterprise SaaS) to biopharma and/or biotech organizations.


• Bachelor’s degree required; advanced degree in life sciences, engineering, or business preferred.


• Proven track record of meeting or exceeding sales targets and driving adoption of complex, high-value technology.


• Familiarity with drug discovery and/ or clinical development workflows.


• Excellent communication and storytelling skills, demonstrated ability to engage both technical and nontechnical audiences.


• Entrepreneurial mindset, with comfort operating in an emerging, fast-scaling business.


• Strong time management and organizational skills; ability to prioritize multiple tasks.


• Familiarity with Sales Lifecycle Management including the use of CRM tools and various databases to document customer interactions.


• Broad-based networking skills; demonstrated ability to build relationships and to communicate at senior management level.


• Ability to be proactive with an energetic and flexible approach.


• Willingness to travel (30%).